High risk screening for Gaucher disease in patients with splenomegaly and/or thrombocytopenia in China: 55 cases identified
- 9 March 2020
- journal article
- research article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 506, 22-27
- https://doi.org/10.1016/j.cca.2020.03.016
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Clinical and molecular characteristics of patients with Gaucher disease in Southern ChinaBlood Cells, Molecules, and Diseases, 2018
- A Review of Gaucher Disease Pathophysiology, Clinical Presentation and TreatmentsInternational Journal of Molecular Sciences, 2017
- A multicentre observational study for early diagnosis of Gaucher disease in patients with Splenomegaly and/or ThrombocytopeniaEuropean Journal of Haematology, 2015
- Chitotriosidase variants in patients with Gaucher disease. Implications for diagnosis and therapeutic monitoringClinical Biochemistry, 2013
- Selective Screening for Lysosomal Storage Diseases with Dried Blood Spots Collected on Filter Paper in 4,700 High-Risk Colombian SubjectsJIMD Reports, 2013
- Clinical and genetic study of Japanese patients with type 3 Gaucher diseaseMolecular Genetics and Metabolism, 2009
- An improved high-throughput dried blood spot screening method for Gaucher diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 2008
- The Clinical and Demographic Characteristics of Nonneuronopathic Gaucher Disease in 887 Children at DiagnosisArchives of Pediatrics & Adolescent Medicine, 2006
- The Gaucher RegistryArchives of Internal Medicine, 2000
- Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.JCI Insight, 1994